Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Classificação em ações #20651
Nuformix plc operates in the field of pharmaceutical development for treating... Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.
Preço da ação
$0.00244926
Valor de mercado
$51.67K
Variação (1 dia)
5.88%
Variação (1 ano)
110.15%
País
GB
Negociar Nuformix plc (NFX)

Categoria

Lucros da Nuformix plc (NFX)
Lucros em Sep 2025 TTM: $-5.28M
De acordo com os últimos relatórios financeiros da Nuformix plc, os ganhos atuais da empresa são de $-5.28M. Em 2024, a empresa teve ganhos de $-4.88M, uma diminuição em relação a aos ganhos de 2023, que foram de $-754.56K. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Nuformix plc de 2014 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
2026 (TTM) $-5.28M 494.63%
2025 $-888.01K -81.80%
2024 $-4.88M 546.72%
2023 $-754.56K -54.82%
2022 $-1.67M -11.94%
2021 $-1.90M 64.37%
2020 $-1.15M -51.92%
2019 $-2.40M -12.87%
2018 $-2.75M 220.48%
2017 $-859.40K 70.68%
2016 $-503.51K -206.04%
2014 $474.83K 0.00%
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
$20.46B -387,521.89%
DK
$4.64B -88,033.93%
US
$5.23B -99,160.13%
US
$2.14B -40,584.12%
BE
$1.61B -30,671.66%
AU